About

SymbioCellTech, LLC, SCT, a Regenerative Medicine Company, was established by clinical academic investigators at the University of Utah, Salt Lake City, USA and University of Hamburg, Germany. The aim of the company is to provide for both humans and companion animals (dogs, cats) a durable cure/treatment using stem cell-based technologies for Type 1 Diabetes Mellitus (T1DM), Type 2 Diabetes Mellitus (T2DM), and microvascular disorders.